Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Bair

Family Medicine Albuquerque, NM Doctor of Osteopathy

NPI 1730188434 CMS profile 33632

8810 Holly Ave Ne Ste F, Albuquerque, NM 87122

Open in the dashboard

General payments

$43,554

135 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Bair of Albuquerque, NM is reported in the CMS Open Payments database as having received $43,554 across 135 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $403 13
2024 General $468 16
2023 General $929 13
2022 General $3,972 16
2021 General $18,770 34
2020 General $10,293 11
2019 General $8,719 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Bair
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Robert Bair were reported at $403. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Robert Bair Family Medicine median Middle half National median
2019 $8,719 $150 $41–$543 $163
2020 $10,293 $120 $32–$415 $114
2021 $18,770 $137 $35–$551 $132
2022 $3,972 $137 $37–$512 $149
2023 $929 $149 $42–$545 $160
2024 $468 $156 $44–$560 $164
2025 $403 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Galderma Laboratories, L.P. $39,978 44 payments
  2. Allergan Inc. $1,386 45 payments
  3. Merz North America, Inc. $649 9 payments
  4. Aerin Medical Inc. $621 2 payments
  5. AbbVie, Inc. $553 26 payments
  6. Revance Therapeutics, Inc. $366 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $37,900 13 payments
  2. Food and Beverage $3,355 106 payments
  3. Travel and Lodging $2,256 11 payments
  4. Education $42 5 payments
Products named General payments · program years 2019–2025
  1. Xeomin $649 9 payments
  2. BOTOX COSMETIC $638 10 payments
  3. VIVAER STYLUS $621 2 payments
  4. BOTOX $504 21 payments
  5. DAXXIFY $366 9 payments
  6. ASCLERA $133 1 payment
  7. DYSPORT $102 1 payment
  8. DYSPORT $100 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

135 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in New Mexico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record